surgery and semaglutide The Potential of Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss After Bariatric Surgery—a Retrospective Analysis | Obesity Weight loss drug semaglutide helps

New FDA regulations and legal actions are phasing out compounded GLP-1s, while companies introduce lower-priced, FDA-approved alternatives.

Discover the evidence on combining these medications, how they work together, potential considerations, and expert guidance on managing nausea during semaglutide treatment for weight management.

One prescription, multiple diseases, and a cascade of transformative outcomes for the industry

GLP-1 receptor agonist drugs protect against diabetic retinopathy, a common complication of diabetes that can lead to sight loss, suggests new research being presented at the annual meeting

Tolerability depends on individual biomarkers, genetic predispositions, dosing strategy, and baseline health status